Europe Breast Cancer Screening Tests Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Europe Breast Cancer Screening Tests Market is Segmented by Test Type (Genomic Tests and Imaging Test) and Geography (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.

Europe Breast Cancer Screening Tests Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Breast Cancer Screening Tests Industry Overview

The Europe breast cancer screening test market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. With the increasing awareness among the population and rising advances in screening test, a few other smaller players are expected to enter the market and may come to hold a substantial share. Some of the major players in the market are Allengers, Myriad Genetics, Hologic Inc., and Siemens Healthineers, among others.

Europe Breast Cancer Screening Tests Market Leaders

  1. Allengers

  2. Myriad Genetics, Inc.

  3. Siemens Healthineers

  4. Hologic Inc.

  5. GE Healthcare

  6. *Disclaimer: Major Players sorted in no particular order
Europe Breast Cancer Screening Tests Market Concentration